A TRISPECIFIC ROR1 X CD3 T CELL ENGAGER MEDIATES IN VITRO TUMOR CELL KILLING AND IN VIVO TUMOR ERADICATION

被引：1

作者：

Chatterjee, Bithi ^{[1
]}

Snell, Daniel ^{[1
]}

Hess, Christian ^{[1
]}

Brock, Matthias ^{[1
]}

Spiga, Fabio ^{[1
]}

Simonin, Alexandre ^{[1
]}

Gunde, Tea ^{[1
]}

Warmuth, Stefan ^{[1
]}

Weinert, Christopher ^{[1
]}

Bassler, Nicole ^{[1
]}

Kirk, Niels ^{[1
]}

Schumacher, Nina ^{[1
]}

Mahler, Dana ^{[1
]}

Yaman, Yasemin ^{[1
]}

Bommer, Bettina ^{[1
]}

Gambino, Giorgio ^{[1
]}

Giezendanner, Noreen ^{[1
]}

Kuettner, Benjamin ^{[1
]}

Flueckiger, Naomi ^{[1
]}

Heiz, Robin ^{[1
]}

Wagen, Sandro ^{[1
]}

Diem, Dania ^{[1
]}

Zeberer, Julia ^{[1
]}

Urech, David ^{[1
]}

机构：

[1] Numab Therapeut, Wadenswil, Switzerland

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.844

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

844

引用

页码：A885 / A885

页数：1

共 50 条

[41] Preclinical characterization of ISB 1342, a CD38 x CD3 T-cell engager for relapsed/refractory multiple myeloma
Pouleau, Blandine
Estoppey, Carole
Suere, Perrine
Nallet, Emilie
Laurendon, Amelie
Monney, Thierry
Ferreira, Daniela Pais
Drake, Adam
Carretero-Iglesia, Laura
Macoin, Julie
Berret, Jeremy
Pihlgren, Maria
Doucey, Marie-Agnes
Gudi, Girish S.
Menon, Vinu
Udupa, Venkatesha
Maiti, Abhishek
Borthakur, Gautam
Srivastava, Ankita
Blein, Stanislas
Mbow, M. Lamine
Matthes, Thomas
Kaya, Zeynep
Edwards, Claire M.
Edwards, James R.
Menoret, Emmanuelle
Kervoelen, Charlotte
Pellat-Deceunynck, Catherine
Moreau, Philippe
Zhukovsky, Eugene
Perro, Mario
Chimen, Myriam
BLOOD, 2023, 142 (03) : 260 - 273
[42] A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells
Riillo, Caterina
Caracciolo, Daniele
Grillone, Katia
Polera, Nicoletta
Tuccillo, Franca Maria
Bonelli, Patrizia
Juli, Giada
Ascrizzi, Serena
Scionti, Francesca
Arbitrio, Mariamena
Lopreiato, Mariangela
Siciliano, Maria Anna
Sestito, Simona
Talarico, Gabriella
Galea, Eulalia
Galati, Maria Concetta
Pensabene, Licia
Loprete, Giovanni
Rossi, Marco
Ballerini, Andrea
Gentile, Massimo
Britti, Domenico
Di Martino, Maria Teresa
Tagliaferri, Pierosandro
Tassone, Pierfrancesco
CANCERS, 2022, 14 (12)
[43] ITPRIPL1 binds CD3 8 to impede T cell activation and enable tumor immune evasion
Deng, Shouyan
Zhang, Yibo
Wang, Huanbin
Liang, Wenhua
Xie, Lu
Li, Ning
Fang, Yuan
Wang, Yiting
Liu, Jiayang
Chi, Hao
Sun, Yufan
Ye, Rui
Shan, Lishen
Shi, Jiawei
Shen, Zan
Wang, Yonggang
Wang, Shuhang
Brosseau, Jean-Philippe
Wang, Feng
Liu, Grace
Quan, Yingfei
Xu, Jie
CELL, 2024, 187 (09) : 2305 - 2323.e33
[44] Mesothelin/CD3 Half-Life-Extended Bispecific T-Cell Engager Molecule Shows Specific Tumor Uptake and Distributes to Mesothelin and CD3-Expressing Tissues
Suurs, Frans, V
Lorenczewski, Grit
Bailis, Julie M.
Stienen, Sabine
Friedrich, Matthias
Lee, Fei
van der Vegt, Bert
de Vries, Elisabeth G. E.
de Groot, Derk-Jan A.
Lub-de Hooge, Marjolijn N.
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (12) : 1797 - 1804
[45] UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma
Caracciolo, Daniele
Polera, Nicoletta
Belmonte, Beatrice
Conforti, Francesco
Signorelli, Stefania
Gulino, Alessandro
Staropoli, Nicoletta
Tuccillo, Franca Maria
Bonelli, Patrizia
Juli, Giada
Grillone, Katia
Ascrizzi, Serena
Cirillo, Maria
Migale, Leonardo
Ballerini, Andrea
Pelizon, Cristina
Di Martino, Maria Teresa
Tagliaferri, Pierosandro
Riillo, Caterina
Tassone, Pierfrancesco
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (02) : 555 - 560
[46] The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
Hudecek, Michael
Schmitt, Thomas M.
Baskar, Sivasubramanian
Lupo-Stanghellini, Maria Teresa
Nishida, Tetsuya
Yamamoto, Tori N.
Bleakley, Marie
Turtle, Cameron J.
Chang, Wen-Chung
Greisman, Harvey A.
Wood, Brent
Maloney, David G.
Jensen, Michael C.
Rader, Christoph
Riddell, Stanley R.
BLOOD, 2010, 116 (22) : 4532 - 4541
[47] The role of CD4+ CD25+ regulatory T cells in allospecific tumor cell killing in vitro.
Drago, K
Hoffmann, P
Ermann, J
Negrin, RS
Edinger, M
BLOOD, 2002, 100 (11) : 822A - 823A
[48] ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells
Carretero-Iglesia, Laura
Hall, Olivia J.
Berret, Jeremy
Pais, Daniela
Estoppey, Carole
Chimen, Myriam
Monney, Thierry
Loyau, Jeremy
Dreyfus, Cyrille
Macoin, Julie
Perez, Cynthia
Menon, Vinu
Gruber, Isabelle
Laurendon, Amelie
Caro, Lydia N.
Gudi, Girish S.
Matsuura, Tomomi
van der Graaf, Piet H.
Blein, Stanislas
Mbow, M. Lamine
Croasdale-Wood, Rebecca
Srivastava, Ankita
Dyson, Michael R.
Matthes, Thomas
Kaya, Zeynep
Edwards, Claire M.
Edwards, James R.
Maiga, Sophie
Pellat-Deceunynck, Catherine
Touzeau, Cyrille
Moreau, Philippe
Konto, Cyril
Drake, Adam
Zhukovsky, Eugene A.
Perro, Mario
Pihlgren, Maria
NATURE CANCER, 2024, 5 (10) : 1494 - 1514
[49] Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager
Eissenberg, Linda G.
Ritchey, Julie K.
Rettig, Michael P.
Patel, Dilan A.
Vij, Kiran
Gao, Feng
Smith, Victoria
Han, Tae H.
Dipersio, John F.
PLOS ONE, 2024, 19 (05):
[50] Diffuse Large B Cell Lymphoma (DLBCL) Expresses ROR1 and a ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Tumor Cells
Hojjat-Farsangi, Mohammad
Ghaderi, Amineh
Daneshmanesh, AmirHossein
Lehto, Jemina
Moshfegh, Ali
Kokhaei, Parviz
Vagberg, Jan
Olsson, Elisabeth
Lofberg, Charlotta
Norstrom, Charlotta Carina
Schultz, Johan
Norin, Martin
Olin, Thomas
Drakos, Elias
Rassidakis, George Z.
Osterborg, Anders
Mellstedt, Hakan
BLOOD, 2019, 134

← 1 2 3 4 5 →